Cel Sci (CVM) Times Interest Earned (2010 - 2026)
Cel Sci (CVM) posted Times Interest Earned of -$0.7 for Q1 2026, up 97.86% sequentially from -$32.63 in Q4 2025, and up 98.06% YoY from -$0.35 in Q1 2025.
Cel Sci (CVM) Times Interest Earned (2010 - 2026) Analysis & Trends
Cel Sci has reported Times Interest Earned for 17 years, with the latest figure at -$0.7 in Q1 2026.
- Quarterly Times Interest Earned rose 98.06% year-over-year to -$0.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.91 (up 88.39% YoY) and the FY2025 annual result came in at -$0.38, up 10.72% from the prior year.
- Times Interest Earned grew to -$0.7 in Q1 2026 per CVM's latest filing, from -$32.63 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.47 in Q4 2023 and troughed at -$155.01 in Q3 2024.
- A 5-year average of -$18.14 and a median of -$0.7 in 2026 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned jumped 99.87% in 2022, then plunged 6939.0% in 2024.
- Over 5 years, Times Interest Earned stood at -$25.5 in 2022, then soared by 98.15% to -$0.47 in 2023, then slumped by 6939.0% to -$33.18 in 2024, then grew by 1.68% to -$32.63 in 2025, then soared by 97.86% to -$0.7 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.7, -$32.63, and -$3.19 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.70 |
| Dec 31, 2025 | -32.63 |
| Sep 30, 2025 | -3.19 |
| Jun 30, 2025 | -0.56 |
| Mar 31, 2025 | -35.92 |
| Dec 31, 2024 | -33.18 |
| Sep 30, 2024 | -155.01 |
| Jun 30, 2024 | -0.54 |
| Mar 31, 2024 | -0.54 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -12.16 |
| Jun 30, 2023 | -0.54 |
| Mar 31, 2023 | -0.52 |
| Dec 31, 2022 | -25.50 |
| Sep 30, 2022 | -5.86 |
| Jun 30, 2022 | -0.49 |
| Mar 31, 2022 | -0.52 |
| Dec 31, 2021 | -30.47 |
| Sep 30, 2021 | -68.34 |
| Jun 30, 2021 | -373.45 |